Should a 71-year-old man with benign prostatic hyperplasia, a chronic Foley catheter, recent Proteus catheter-associated urinary tract infection treated with levofloxacin and currently on ceftriaxone, who now has scrotal pain and a contaminated urine culture, receive an urgent scrotal/testicular Doppler ultrasound and urgent urology follow-up for catheter exchange with repeat urinalysis and culture, and have ceftriaxone discontinued after a seven‑day course rather than extended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Scrotal Pain in a Catheterized Patient with Recent CAUTI

Yes, obtain an urgent scrotal ultrasound with Doppler immediately to evaluate for epididymitis, orchitis, or abscess, arrange urgent urology follow-up for catheter exchange with repeat culture from the new catheter, and discontinue ceftriaxone after completing the 7-day course given the contaminated culture and clinical improvement.

Rationale for Scrotal Imaging

New scrotal pain in this clinical context is concerning for epididymitis, which occurs in up to 90% of cases from pathogen migration from the urethra or bladder 1. Given his chronic Foley catheter and recent Proteus CAUTI, he is at high risk for ascending infection. The 2024 EAU guidelines explicitly recommend urgent evaluation when scrotal symptoms develop, as the diagnostic algorithm for acute scrotal pain prioritizes ruling out torsion first, then evaluating for infectious causes 1.

Key clinical pitfall: Do not delay imaging based on the contaminated culture result. The contaminated specimen does not exclude active infection—it simply means you need a proper specimen after catheter exchange. Scrotal pain represents a new anatomical site of potential infection that requires immediate assessment.

Catheter Management Strategy

Catheter exchange is mandatory for two critical reasons 1:

  • Management of the underlying complicating factor is strongly recommended for all complicated UTIs 1. The chronic Foley itself is the primary complicating factor and source of recurrent infection
  • Proper specimen collection requires catheter replacement in CAUTI cases. Cultures obtained from chronically indwelling catheters are unreliable due to biofilm colonization 2, 3

The contaminated culture you obtained reflects the polymicrobial biofilm on the existing catheter surface rather than true invasive infection. Proteus species are notorious for forming crystalline biofilms on catheters, leading to encrustation and serving as a nidus for recurrent infection 3.

Antibiotic Duration Decision

Discontinue ceftriaxone after 7 days based on the following evidence 1:

  • Treatment duration of 7 days is appropriate for hemodynamically stable patients who have been afebrile for at least 48 hours 1
  • The guideline specifically states 7-14 days for complicated UTI in men (14 days when prostatitis cannot be excluded) 1
  • Your patient has clinically improved with resolution of urinary symptoms, indicating treatment response
  • The contaminated culture provides no actionable data to guide extended therapy

However, reassess after catheter exchange: If the new culture from the fresh catheter grows a pathogen and he has epididymitis confirmed on ultrasound, you will need to restart appropriate antibiotics based on susceptibilities. Epididymitis typically requires treatment targeting Enterobacterales (the likely pathogens given his history) 1.

Specific Management Algorithm

Immediate actions (today):

  1. Order STAT scrotal ultrasound with Doppler
  2. Contact urology for urgent catheter exchange
  3. Collect urine culture from the newly placed catheter using aseptic technique
  4. Complete the 7-day ceftriaxone course but do not extend it

If ultrasound confirms epididymitis:

  • Initiate empiric therapy covering Enterobacterales while awaiting new culture results 1
  • Consider parenteral therapy if severe infection 1
  • The 2024 EAU algorithm recommends single antibiotic or combination therapy active against Enterobacterales for epididymitis when gonorrhea is unlikely (which applies here given his age and chronic catheter) 1

If ultrasound shows abscess:

  • Requires drainage in addition to antibiotics 1
  • Urgent urology intervention needed

If new culture grows organism:

  • Tailor antibiotics to susceptibilities
  • Treat for 7-14 days depending on clinical response and whether prostatitis is suspected 1

Critical Risk Factors in This Patient

This 71-year-old has multiple high-risk features for complicated outcomes 1, 4:

  • Chronic catheterization (the single most important risk factor for CAUTI) 1
  • BPH with urinary retention (underlying urological abnormality requiring management) 1, 5, 4
  • Recent Proteus CAUTI (Proteus forms crystalline biofilms and causes catheter encrustation) 3
  • Male sex with UTI (automatically classified as complicated UTI) 1

The mortality associated with CAUTI-related bacteremia is approximately 10% 1, making aggressive evaluation and source control essential.

Avoiding Common Pitfalls

Do not:

  • Treat based on the contaminated culture—it's clinically meaningless
  • Delay imaging because he's "stable"—epididymitis can progress to abscess or Fournier's gangrene
  • Continue antibiotics indefinitely without a clear indication
  • Ignore the underlying BPH—this needs definitive urological management to prevent recurrence 1, 5

Do:

  • Act urgently on new anatomical site symptoms (scrotal pain)
  • Replace the catheter before obtaining diagnostic specimens
  • Coordinate closely with urology for both acute management and long-term catheter alternatives 6

Related Questions

In a 75-year-old man with an indwelling urinary catheter for benign prostatic hyperplasia who is asymptomatic but has a urine culture growing Klebsiella (>10⁵ CFU/mL) susceptible to ciprofloxacin, amikacin, and co‑trimoxazole, should antimicrobial therapy be started or is the appropriate management simply to proceed with the scheduled catheter change?
In a 71-year-old man with benign prostatic hyperplasia, a chronic indwelling Foley catheter, and recurrent catheter-associated urinary tract infections who recently completed levofloxacin for a Proteus urinary infection, should the Foley catheter be exchanged and a repeat urinalysis and urine culture obtained from the new catheter, and should ceftriaxone be discontinued now that his urinary symptoms have resolved?
What are the recommended interventions to prevent catheter-associated urinary tract infections (CAUTI)?
What is the appropriate antibiotic regimen for a catheter-associated urinary tract infection (CAUTI) presenting with leukocytosis?
What is the appropriate management of catheter-associated urinary tract infection (CAUTI)?
Can clindamycin be used to treat both a pedicure-related toe infection and a dental infection in the same patient?
What medications are appropriate for a 53-year-old patient with irritable bowel syndrome, a history of constipation only twice, thyroid disease, and multiple prior concussions from motorcycle racing?
Is the medication for the patient supplied as capsules or tablets?
What oxaliplatin dose should be reduced to from 85 mg/m² for a platelet count of 64 × 10⁹/L?
Does a rash on my neck and throat after taking Augmentin (amoxicillin‑clavulanate) qualify as a documented penicillin allergy?
How should Neosporin (bacitracin, neomycin, polymyxin B) be applied, what are its contraindications, and what alternatives exist for patients allergic to its components?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.